MedPath

Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)

Conditions
Neoplasm, Stomach
Chronic Atrophic Gastritis
H. Pylori Infection
Registration Number
NCT03597672
Lead Sponsor
Jian-Kun Hu
Brief Summary

To establish prospective cohort of healthy population and corresponding serum sample bank in Sichuan province to provide platform for exploring early diagnosis and screening strategy of gastric cancer by a prospective cohort study.

Detailed Description

H. pylori was one of the most important carcinogenic factor for gastric cancer and play a crucial role in inducing gastritis, atrophy and canceration. Chronic atrophic gastritis (CAG) was a common precancerous disease, people with CAG become high-risk population and need regular follow-up. However, study about occurrence risk prediction for gastric cancer when H. pylori infection concurrence with CAG was still spare. In especial, there was still no population screening program based on serology. The relative clinical epidemiology for providing evidence for China gastric cancer screening program was very rare.

This study aim to evaluate gastric cancer occurrence risk and diagnostic value of people combined with H. pylori infection and CAG by Serological methods in Sichuan province China. We also project to design optimized screening program suitable for people in sichuan province China.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30000
Inclusion Criteria
  1. Inhabitant in Sichuan province in China (length of residence > 10 years);
  2. Complete physical examination in our hospital, the outcomes was asymptomatic and cancer free healthy individuals;
  3. Age between 20 and 70;
  4. With normal cognitive and communication ability;
  5. Without gastroscopy during recruitment, physical examination item including gastroscopy enrolled in prospective cohort study;
  6. Wiling to accept 1-2 times routine physical examination in our hospital;
  7. Agree to accept the follow-up of our project group;
Exclusion Criteria
  1. With history of malignant tumor;
  2. Refuse to donate blood specimen;
  3. With serious comorbidity and/or finite life (less than 5 years);
  4. Request to retreat from this study;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of new cases of gastric carcinoma5 years

The new cases of gastric and other epidermal malignant tumor

Secondary Outcome Measures
NameTimeMethod
Time of finding nee cases5 years

The time during SIGES when finding nee gastric cancer and relative disease

Trial Locations

Locations (1)

Jian-Kun Hu

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath